Key result
Repression of KREPB3 (KREN2) expression in Trypanosoma brucei strongly inhibited cell growth and in vivo editing, and blocked cleavage of insertion editing substrates in vitro.
KREPB3 (KREN2) is identified as an essential RNA editing endonuclease specific for insertion sites in Trypanosoma brucei.
May guide antiparasitic drug development for trypanosomiasis; leaves open selective human targeting.
RNA editing adds and deletes uridine nucleotides in many preedited mRNAs to create translatable mRNAs in the mitochondria of the parasite Trypanosoma brucei. Kinetoplastid RNA editing protein B3 (KREPB3, formerly TbMP61) is part of the multiprotein complex that catalyzes editing in T. brucei and contains an RNase III motif that suggests nuclease function. Repression of KREPB3 expression, either by RNA interference in procyclic forms (PFs) or by conditional inactivation of an ectopic KREPB3 allele in bloodstream forms (BFs) that lack both endogenous alleles, strongly inhibited growth and in vivo editing in PFs and completely blocked them in BFs. KREPB3 repression inhibited cleavage of insertion editing substrates but not deletion editing substrates in vitro, whereas the terminal uridylyl transferase, U-specific exoribonuclease, and ligase activities of editing were unaffected, and approximately 20S editosomes were retained. Expression of KREPB3 alleles with single amino acid mutations in the RNase III motif had similar consequences. These data indicate that KREPB3 is an RNA editing endonuclease that is specific for insertion sites and is accordingly renamed KREN2 (kinetoplastid RNA editing endonuclease 2).
No takes yet. Share an insight, caveat, or question.
Carnes et al. (2005) studied Trypanosoma brucei biology. KREPB3 (KREN2) repression vs. Unrepressed KREPB3 expression was evaluated on Cell growth, in vivo RNA editing, and in vitro endonuclease cleavage of insertion substrates. Repression of KREPB3 (KREN2) expression in Trypanosoma brucei strongly inhibited cell growth and in vivo editing, and blocked cleavage of insertion editing substrates in vitro.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: